Drug class
Follicle-Stimulating Hormone (FSH)
Follicle-stimulating hormone (FSH) agents form a therapeutic class of gonadotropins comprising recombinant or highly purified human-derived hormones that mimic endogenous pituitary FSH. Read more about Follicle-Stimulating Hormone (FSH)
6 drugs in this class 4 manufacturers
Drugs in Follicle-Stimulating Hormone (FSH)
GONAL-F (follitropin alfa, recombinant)
MENOPUR (menotropins)
GONAL-F RFF REDI-JECT (follitropin alfa, recombinant)
FOLLISTIM AQ (follitropin beta,recombinant)
FOLLISTIM AQ (follitropin beta,recombinant)
Follicle-stimulating hormone (FSH) agents form a therapeutic class of gonadotropins comprising recombinant or highly purified human-derived hormones that mimic endogenous pituitary FSH.
These medications exert their effects by selectively binding to transmembrane FSH receptors on gonadal tissue, which stimulates follicular growth and maturation in ovarian granulosa cells and supports spermatogenesis in testicular Sertoli cells.
Clinically, FSH agents are indicated primarily in reproductive endocrinology to induce ovulation in anovulatory infertility, drive controlled ovarian hyperstimulation for assisted reproductive technology procedures, and promote sperm production in males with hypogonadotropic hypogonadism.
-
fda.gov
Follicle-stimulating hormone (FSH) agents form a therapeutic class of gonadotropins comprising recombinant or highly purified human-derived hormones that mimic endogenous pituitary FSH
-
reproductivefacts.org
Follicle-stimulating hormone (FSH) agents form a therapeutic class of gonadotropins comprising recombinant or highly purified human-derived hormones that mimic endogenous pituitary FSH
-
fda.gov
These medications exert their effects by selectively binding to transmembrane FSH receptors on gonadal tissue, which stimulates follicular growth and maturation in ovarian granulosa cells and supports spermatogenesis in testicular Sertoli cells Clinically, FSH agents are indicated primarily in reproductive endocrinology to induce ovulation in anovulatory infertility, drive controlled ovarian hyperstimulation for assisted reproductive technology procedures, and promote sperm production in males w...
-
nih.gov
These medications exert their effects by selectively binding to transmembrane FSH receptors on gonadal tissue, which stimulates follicular growth and maturation in ovarian granulosa cells and supports spermatogenesis in testicular Sertoli cells
-
mayoclinic.org
Clinically, FSH agents are indicated primarily in reproductive endocrinology to induce ovulation in anovulatory infertility, drive controlled ovarian hyperstimulation for assisted reproductive technology procedures, and promote sperm production in males with hypogonadotropic hypogonadism
Sign in to follow this class
Following a drug class requires a free Physicians Office Resource account.